Mepivacaine HCL en es it fr

Mepivacaine HCL Brand names, Mepivacaine HCL Analogs

Mepivacaine HCL Brand Names Mixture

  • No information avaliable

Mepivacaine HCL Chemical_Formula


Mepivacaine HCL RX_link

Mepivacaine HCL fda sheet

Mepivacaine_HCL FDA

Mepivacaine HCL msds (material safety sheet)

Mepivacaine_HCL MSDS

Mepivacaine HCL Synthesis Reference

No information avaliable

Mepivacaine HCL Molecular Weight

129.164 g/mol

Mepivacaine HCL Melting Point

223-226 oC

Mepivacaine HCL H2O Solubility

Freely soluble as HCl salt

Mepivacaine HCL State


Mepivacaine HCL LogP


Mepivacaine HCL Dosage Forms

Extended release tablet (500 mg or 1000 mg)

Mepivacaine HCL Indication

For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.

Mepivacaine HCL Pharmacology

Metformin is an antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may actually decrease.

Mepivacaine HCL Absorption

Absorbed over 6 hours, bioavailability is 50 to 60% under fasting conditions. Food delays absorption.

Mepivacaine HCL side effects and Toxicity

Acute oral toxicity (LD50): 350 mg/kg [Rabbit]. It would be expected that adverse reactions of a more intense character including epigastric discomfort, nausea, and vomiting followed by diarrhea, drowsiness, weakness, dizziness, malaise and headache might be seen.

Mepivacaine HCL Patient Information

Mepivacaine HCL Organisms Affected

Humans and other mammals